Chapter 7 The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease
- 1 January 1986
- book chapter
- Published by Elsevier
- Vol. 70, 105-132
- https://doi.org/10.1016/s0079-6123(08)64300-9
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Neuron loss in the nucleus basalis of meynert in parkinsonism‐dementia complex of GuamAnnals of Neurology, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortexLife Sciences, 1982
- Muscarinic receptor binding in mouse brain: Regulation by guanine nucleotidesBiochemical and Biophysical Research Communications, 1980
- Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenaseNeuroscience Letters, 1980
- Guanine nucleotides modulate muscarinic receptor binding in the heartBiochemical and Biophysical Research Communications, 1979
- Inositol phospholipids and cell surface receptor functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1975
- Choline acetylase and acetylcholine esterase changes in chronic isolated cerebral cortex of catLife Sciences, 1970
- Über das Elektrenkephalogramm des MenschenArchiv Fur Psychiatrie Und Nervenkrankheiten, 1933